Back to search

Article

Vascular Phenotyping in Parkinson’s Disease: Diabetes Mellitus Operationalizes a Microvascular Metabolic Syndrome Cluster Across PPMI Diagnostic Cohorts

2026-06-11

Abstract excerpt

<h4>Background</h4> Diabetes mellitus elevates Parkinson’s disease (PD) risk, via hypothesized cerebrovascular mediation. Whether the diabetes/prediabetes vascular-risk phenotype concentrates in cardiometabolic risk or macrovascular events across prodromal and clinically diagnosed PD remains unresolved. <h4>Objectives</h4> To quantify the vascular-risk burden associated with diabetes/prediabetes across the PPMI...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7680bc0f-0ced-5086-a076-3ff1ae262d65
DOI
10.64898/2026.06.09.26355285
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Vascular Phenotyping in Parkinson’s Disease: Diabetes Mellitus Operationalizes a Microvascular Metabolic Syndrome Cluster Across PPMI Diagnostic CohortsDOI 10.64898/2026.06.09.26355285
Data-driven subtypes of type 2 diabetes mellitus and risk of dementia, stroke, and brain structural changes in the UK BiobankSemantic proximity
Association of cholesterol and glycemic state biomarkers with phenotypic variation and Parkinson's disease progression: The Oxford Discovery cohort.Semantic proximity
Causes and consequences of vascular dementia across the life course: Evidence from a UK Biobank phenome-wide and Mendelian randomization studySemantic proximity
Distinct metabolic signatures of Alzheimer's and Parkinson's disease revealed through genetic overlap.Semantic proximity
The relationship between neuropsychiatric dimensions and markers of Parkinson's disease risk in the UK BiobankSemantic proximity
Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.Semantic proximity
Distinct metabolic signatures of Alzheimer’s and Parkinson’s disease revealed through genetic overlap with metabolic markersSemantic proximity
Triglyceride-Glucose Indices, Genetic Susceptibility, and Incident Dementia Risk Across Early CKM Syndrome Stages: A UK Biobank Prospective Cohort StudySemantic proximity
Additive effects of cerebrovascular disease functional connectome phenotype and plasma p-tau181 on longitudinal neurodegeneration and cognitive outcomesSemantic proximity
Characterizing the distinct neuroanatomical phenotypes, cognitive profiles, and transcriptomic signatures of brain structural subtypes in Parkinson's disease with mild cognitive impairment.Semantic proximity
Phenotypic Multiorgan Involvement of Subclinical Disease as Quantified by Magnetic Resonance Imaging in Subjects With Prediabetes, Diabetes, and Normal Glucose Tolerance.Semantic proximity
Diabetes mellitus, glycemic traits, and cerebrovascular disease: a Mendelian randomization studySemantic proximity
Select a neighboring publication to make it the new centre.